AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
LMND vs EVER: Which InsurTech Stock Offers Better Growth Potential?
ByAinvest
Thursday, Dec 18, 2025 11:56 am ET1min read
Lemonade (LMND) and EverQuote (EVER) are InsurTechs facing challenges due to lowered interest rates, increased competition, and regulatory scrutiny. LMND has diversified its business beyond renters and homeowners insurance, with a strong focus on customer retention and subscription-driven model. EVER is well-positioned for long-term growth, with a robust digital platform and a focus on data-driven underwriting. Both companies are investing in regtech solutions to overcome compliance challenges. LMND is projected to reach $727 million to $732 million in revenues by 2025, while EVER is expected to grow its in-force premium by 30% in fiscal 2026.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet